Research use only. Not for human consumption.
About

Precision research supply,
built for clarity.

Vivaprime is a next-generation research peptide supplier. We source every compound from a licensed EU pharmaceutical facility, deliver them in sealed, pre-dosed pens, and ship cold-chain from our US warehouse to researchers across the country.

The approach

Eliminate the variables that muddy research

Most research peptide suppliers ship vials that require reconstitution with bacteriostatic water, careful dosing calculations, and careful storage. Every step introduces variance. Vivaprime ships sealed, factory-dosed prefilled pens — calibrated at source, verified by batch.

Operations

Canadian corporate entity, US fulfillment

Vivaprime is operated as a Canadian federal corporation, with $1M+ product liability insurance covering US-based claims. Fulfillment is handled by a cold-chain-capable US 3PL. Our payment stack is built for stability (high-risk merchant processor + crypto redundancy).

Third-party COAs

Every batch tested for identity, purity, and residual solvents. Linked on every PDP.

EU-manufactured

Licensed pharmaceutical facility operating under pre-registered specs.

Cold-chain shipped

From our US 3PL with validated insulation and phase-change packs.

Research-use only

Sold for in-vitro research by qualified researchers — no therapeutic claims.

Published research

A starting point in the literature

Every compound we supply has a published research record. The citations below are peer-reviewed starting points — not claims of efficacy, safety, or intended use. For the compounds we sell, we keep links to representative papers so researchers can orient themselves in the primary literature.

  • Compound
    Semaglutide
    Long-acting GLP-1 receptor agonist; peptide-structure and pharmacology review

    Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol. 2019;10:155.

    doi.org/10.3389/fendo.2019.00155
  • Compound
    Tirzepatide
    Dual GIP/GLP-1 receptor agonist mechanism overview

    Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist. Mol Metab. 2018;18:3-14.

    doi.org/10.1016/j.molmet.2018.09.009
  • Compound
    BPC-157
    Pentadecapeptide from gastric juice; tissue-repair pathway review

    Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut axis and pentadecapeptide BPC 157. Curr Neuropharmacol. 2016;14(8):857-865.

    doi.org/10.2174/1570159X13666160502153022
  • Compound
    TB-500 / Thymosin β4
    Actin sequestration, angiogenesis, and soft-tissue research background

    Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.

    doi.org/10.1517/14712598.2012.634793
  • Compound
    GHK-Cu
    Copper-peptide complex in skin remodeling research

    Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci. 2018;19(7):1987.

    doi.org/10.3390/ijms19071987
  • Compound
    Epithalon
    Tetrapeptide; telomerase-activation research review

    Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592.

    doi.org/10.1023/a:1025493705728

Citations above are representative, not exhaustive. Our products are sold for in-vitro research by qualified researchers. References to published work do not constitute therapeutic, diagnostic, or consumption claims.

What we won't do

No therapeutic claims. No shortcuts.

Every page on this site is written as research reference. Every batch ships with a COA. Every order is placed by a researcher who has affirmed the research-use agreement. We don't cut corners on sourcing, storage, or compliance — our whole business model depends on not cutting them.